Search

Displaying results 8551 - 8560 of 10000 in total
  1. Drug

    CN-105

    go.drugbank.com/drugs/DB18345
    Investigational

    CN-105 is a neuroprotective pentapeptide with the sequence Acetyl-Valine-Serine-Arginine-Arginine-Arginine-NH2 (Ac-VSRRR- NH2).

  2. Drug

    Elebsiran

    go.drugbank.com/drugs/DB19018
    Investigational

    Elebsiran is under investigation in clinical trial NCT05461170 (SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.).

  3. Drug

    Briciclib

    go.drugbank.com/drugs/DB12004
    Investigational

    Briciclib has been used in trials studying the treatment of Lymphoma, Neoplasms, Advanced Solid Tumor, and Acute Lymphocytic Leukemia.

  4. Drug

    Ninvosudil

    go.drugbank.com/drugs/DB08756
    Investigational

    Y-27632 is an inhibitor of Rho-associated protein kinase. It inhibits calcium sensitization to affect smooth muscle relaxation.

    Synonyms: (R)-(+)-trans-N-(4-pyridyl)-4-(1-aminoethyl)-cyclohexanecarboxamide, 4-[(1R)-1-aminoethyl]-N-(pyridin-4-yl)cyclohexane-1-carboxamide
  5. Drug

    TG4023

    go.drugbank.com/drugs/DB06108
    Investigational

  6. Drug

    Alovudine

    go.drugbank.com/drugs/DB06198
    Investigational

  7. Drug

    Hydronidone

    go.drugbank.com/drugs/DB06299
    Investigational

    Hydronidone has antifibrotic activity.

    Synonyms: N-(4-Hydroxyphenyl)-5-methyl-2-pyridone
  8. Drug

    Aprinocarsen

    go.drugbank.com/drugs/DB06451
    Investigational

    Aprinocarsen is a specific antisense oligonucleotide inhibitor of protein kinase C-alpha.

  9. Drug

    Dextrin 2-sulfate

    go.drugbank.com/drugs/DB06496
    Investigational

  10. Drug

    MLN576

    go.drugbank.com/drugs/DB06517
    Experimental

    XR11576 (MLN576) is a novel monophenazine with a mechanism of action that includes interaction with both topoisomerase (Topo) I and II.